Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 ECLS-related complications

From: Therapeutic hypothermia in adult patients receiving extracorporeal life support: early results of a randomized controlled study

Variable All patients n = 21 (%) Hypothermia n = 9 (%) Normothermia n = 12 (%) P-value
Duration of ECLS (days) 4.4 ± 2.7 4.1 ± 1.8 4.6 ± 3.2 0.675
Bleeding 5 (23.8) 2 (22.2) 3 (25.0) 0.882
Intracranial haemorrhage 1 (4.8) 0 (0) 1 (8.3) 0.375
Intrathoracic or intra-abdominal 3 (14.3) 1 (11.1) 2 (16.7) 0.719
PCT / day of ECLS (units) 2.6 ± 2.0 2.2 ± 1.7 2.9 ± 2.2 0.484
New arrhythmias 4 (19.0) 2 (22.2) 2 (16.7) 0.748
Limb ischaemia 6 (28.6) 2 (22.2) 4 (33.3) 0.577
Distal perfusion cannula 13 (61.9) 6 (66.7) 7 (58.3) 0.697
Acute renal failure 19 (90.5) 8 (88.9) 11 (91.7) 0.830
CRRT 18 (85.7) 7 (77.8) 11 (91.7) 0.368
Pneumonia 7 (33.3) 1 (11.1) 6 (50.0) 0.061
  1. Values for parametric continuous variables are expressed as mean ± standard deviation. Values for categorical variables are expressed as numbers (%)
  2. CRRT continuous renal replacement therapy, ECLS Extracorporeal life support, PCT packed cell transfusion